The Food and Drug Administration (FDA) has expanded the approval of Repatha ® (evolocumab) to include use in adults at increased risk for major adverse cardiovascular events (MACE) due to uncontrolled ...

Omidubicel is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy derived from umbilical cord blood.

The IV formulation of efgartigimod alfa is currently approved under the brand name Vyvgart for the treatment of gMG in adult patients who are anti-acetylcholine receptor antibody positive.

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.

All types of climate-related disasters were declared in at least one county with an active drug production facility, with hurricanes most common.

Associations seen for vaping and subsequent smoking, substance use, asthma, cough, injuries, and poor mental health.

Use of AI-drafted clinical notes from clinician-patient conversations also improves perceived documentation-related well-being.

HealthDay News — Prenatal exposure to the pesticide chlorpyrifos (CPF) is associated with altered differentiation of neuronal tissue, increased myelination of the internal capsule, and lower regional ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

In October 2024, Imuldosa received approval from the Food and Drug Administration based on data from the phase 3 Opportuniti ...

HealthDay News — For patients 50 years or older at high cardiovascular risk without diabetes or prior stroke, an intensive systolic blood pressure (SBP) target (<120 mm Hg) seems cost-effective at ...

OTC access linked to 31.8 percentage point increase in individuals moving from no contraceptive method to an effective method.